An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
暂无分享,去创建一个
K. Leon | T. Crombet | Z. Mazorra | D. Saavedra | C. Valenzuela | L. Filgueira | C. Herrera | Naivy Sánchez | M. Cepeda | M. Ramos | A. L. Añe-Kouri | A. Caballero | J. Betancourt | Leniel Manso | Elibet Chávez | C. Hidalgo | Geydi Lorenzo